Last reviewed · How we verify

NCT04690010

Ambulatory Versus Inpatient Percutaneous Nephrolithotomy

Status unknown NA Last updated 20 December 2023
What this trial tests

NA trial testing Ambulatory tubeless PCNL in Kidney Calculi in 140 participants. Status unknown.

Timeline
8 January 2022
Primary endpoint
30 December 2023
30 December 2024

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment140
Start date8 January 2022
Primary completion30 December 2023
Estimated completion30 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, any sex, with Kidney Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to determine if ambulatory tubeless PCNL is safe and effective compared to inpatient PCNL with a nephrostomy tube.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Kidney Calculi

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04690010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing